KRRO - Korro Bio, Inc. Common Stock

Day	1m	10m	60m	PreMarket	Market	AfterHours	Gap
45.78 6.21 (13.56%)	---	0.0 (0.0%)	0.0 (0.0%)	---	5.58 (12.19%)	0.0 (0.0%)	0.0 (0.0%)

Korro Bio Inc is a biopharmaceutical company with a mission to discover, develop, and commercialize a new class of genetic medicines based on editing RNA, enabling the treatment of both rare and highly prevalent diseases. It is generating a portfolio of differentiated programs that are designed to harness the body's natural RNA editing process to effect a precise yet transient single base edit. By editing RNA instead of DNA, Korro Bio is expanding the reach of genetic medicines by delivering additional precision and tunability.

Category: PHARMACEUTICAL PREPARATIONS

Market Period: Closed

Earnings & Ratios

Basic EPS:: -2.74
Diluted EPS:: -2.74
Basic P/E:: -18.9745
Diluted P/E:: -18.9745
RSI(14) 1m:: 100.0
VWAP:: 51.99
RVol:: 1.5693

Events

Period	Kind	Movement	Occurred At
1m	Price increase 1m	50.6 +0.6 (+1.2%)	Oct 15 15:53
1m	Price increase 1m	49.82 +0.51 (+1.03%)	Oct 15 15:44
1m	Price decrease 1m	50.33 -0.71 (-1.39%)	Oct 15 15:10
1m	Price increase 1m	52.0 +1.22 (+2.4%)	Oct 15 15:02
10m	Price decrease 10m	51.21 -1.73 (-3.27%)	Oct 15 14:36